Thus during the treatment of heart failure, these results are consistent with both ACE-inhibitor and ARB therapy decreasing Ang II mediated signaling to alter the vascular phenotype by preventing the fall in LZ+ MYPT1 expression. This evidence concerns the gene PPP1R12A and heart failure.